Barely Significant
← all excerpts

Sirolimus Monotherapy for Thrombocytopenia in Primary Antiphospholipid Syndrome: A Pilot Study From a Tertiary Referral Center.

Front Immunol · 2022 · PMC8989728 · PMID 35401500

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

an increasing trendp < 0.001actually significant
Overall, the platelet count of included patients exhibited an increasing trend after administration of sirolimus (p < 0.001).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.